Sarepta Therapeutics, Inc.SRPTNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank7
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-699.78M
↓ 84% vs avg
Percentile
P7
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-379.72M
Historical baseline
PeriodValueYoY Change
TTM$-699.78M-420.9%
2024$218.08M+181.4%
2023$-267.82M+50.1%
2022$-536.20M-16.6%
2021$-459.71M+18.5%
2020$-564.16M+20.0%
2019$-705.56M-105.3%
2018$-343.63M-100.2%
2017$-171.64M+35.7%
2016$-266.73M-